FDA Center for Drug Evaluation & Research Issues Warning Letter to Eurofins SF Analytical Laboratories
October 14, 2026
October 14, 2026
WASHINGTON, Oct. 14 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Eurofins SF Analytical Laboratories Inc. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. David Riggs, President - EFSA Cluster, Eurofins SF Analytical Laboratories, Inc., 2345 South 170th Street, New Berlin, WI 53151, United States
(b)(4)
Issuing Office: Center for Drug Evaluation and . . .
* * *
Recipient: Mr. David Riggs, President - EFSA Cluster, Eurofins SF Analytical Laboratories, Inc., 2345 South 170th Street, New Berlin, WI 53151, United States
(b)(4)
Issuing Office: Center for Drug Evaluation and . . .